Log in to save to my catalogue

Leukemia stemness and co-occurring mutations drive resistance to IDH inhibitors in acute myeloid leu...

Leukemia stemness and co-occurring mutations drive resistance to IDH inhibitors in acute myeloid leu...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_af530f137f2d430f8c1dd47dd38789db

Leukemia stemness and co-occurring mutations drive resistance to IDH inhibitors in acute myeloid leukemia

About this item

Full title

Leukemia stemness and co-occurring mutations drive resistance to IDH inhibitors in acute myeloid leukemia

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2021-05, Vol.12 (1), p.2607-2607, Article 2607

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Allosteric inhibitors of mutant IDH1 or IDH2 induce terminal differentiation of the mutant leukemic blasts and provide durable clinical responses in approximately 40% of acute myeloid leukemia (AML) patients with the mutations. However, primary resistance and acquired resistance to the drugs are major clinical issues. To understand the molecular un...

Alternative Titles

Full title

Leukemia stemness and co-occurring mutations drive resistance to IDH inhibitors in acute myeloid leukemia

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_af530f137f2d430f8c1dd47dd38789db

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_af530f137f2d430f8c1dd47dd38789db

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-021-22874-x

How to access this item